Table 2.
Literature | Year | Patients or LN dissections | Patients or LN dissections with positive histology | Positive nodes (mean) | PSA at time of PET/CT diagnosis (mean, ng/ml) | Biochemical response (%) | Complete biochemical response without adjuvant therapy in patients with histologically confirmed LN metastases | |||
---|---|---|---|---|---|---|---|---|---|---|
PSA <0.2 ng/ml | follow-up (month, mean) | PSA <0.01 ng/ml | follow-up (month, mean) | |||||||
Scattoni et al. [1] | 2007 | 25 | 19 (76%) | 8.8 | 1.98 | NA | NA | NA | NA | NA |
Rigatti et al. [2] | 2011 | 72 | 60 (83%) | 9.8 | 3.7 | 57 | 4 of 28 patients | 38.9 | NA | NA |
Jilg et al. [10] | 2012 | 52† | 47 (90%)† | 9.7 | 3.9 | 46 | NA | NA | NA | NA |
Martini et al. [13] | 2012 | 8 | 6 (75%) | 1.0 | 1.6 | 67 | NA | NA | NA | NA |
Winter et al. | 13 | 11 (85%) | 1.0 | 2.7 | 90 | 5 of 10 patients | 41.4 | 3 of 10 patients | 64 (max. 83) |
†LN dissections.
LN = lymph node, NA = not available.